Cargando…

Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry

A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in the first second FEV(1) percent predicted (FEV(1)pp). This study aimed to address challenges in identifying predictors of FEV(1)pp, specifically dealing with non-linearity and the censoring effect of de...

Descripción completa

Detalles Bibliográficos
Autores principales: Earnest, Arul, Salimi, Farhad, Wainwright, Claire E., Bell, Scott C., Ruseckaite, Rasa, Ranger, Tom, Kotsimbos, Tom, Ahern, Susannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567842/
https://www.ncbi.nlm.nih.gov/pubmed/33060788
http://dx.doi.org/10.1038/s41598-020-74502-1
_version_ 1783596407975837696
author Earnest, Arul
Salimi, Farhad
Wainwright, Claire E.
Bell, Scott C.
Ruseckaite, Rasa
Ranger, Tom
Kotsimbos, Tom
Ahern, Susannah
author_facet Earnest, Arul
Salimi, Farhad
Wainwright, Claire E.
Bell, Scott C.
Ruseckaite, Rasa
Ranger, Tom
Kotsimbos, Tom
Ahern, Susannah
author_sort Earnest, Arul
collection PubMed
description A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in the first second FEV(1) percent predicted (FEV(1)pp). This study aimed to address challenges in identifying predictors of FEV(1)pp, specifically dealing with non-linearity and the censoring effect of death. Data was obtained from a large multi-centre Australian Cystic Fibrosis Data Registry (ACFDR). A linear mixed model was used to study FEV(1)pp as the endpoint. There were 3655 patients (52.4% male) included in our study. Restricted cubic splines were used to fit the non-linear relationship between age of visit and FEV(1)pp. The following predictors were found to be significant in the multivariate model: age of patient at visit, BMI z-score, age interaction with lung transplantation, insulin dependent diabetes, cirrhosis/portal hypertension, pancreatic insufficiency, Pseudomonas aeruginosa infection and baseline variability in FEV(1)pp. Those with P. aeruginosa infection had a lower mean difference in FEV(1)pp of 4.7 units, p < 0.001 compared to those who did not have the infection. Joint modelling with mortality outcome did not materially affect our findings. These models will prove useful for to study the impact of CFTR modulator therapies on rate of change of lung function among patients with CF.
format Online
Article
Text
id pubmed-7567842
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75678422020-10-19 Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry Earnest, Arul Salimi, Farhad Wainwright, Claire E. Bell, Scott C. Ruseckaite, Rasa Ranger, Tom Kotsimbos, Tom Ahern, Susannah Sci Rep Article A key measure of lung function in people with Cystic Fibrosis (CF) is Forced Expiratory Volume in the first second FEV(1) percent predicted (FEV(1)pp). This study aimed to address challenges in identifying predictors of FEV(1)pp, specifically dealing with non-linearity and the censoring effect of death. Data was obtained from a large multi-centre Australian Cystic Fibrosis Data Registry (ACFDR). A linear mixed model was used to study FEV(1)pp as the endpoint. There were 3655 patients (52.4% male) included in our study. Restricted cubic splines were used to fit the non-linear relationship between age of visit and FEV(1)pp. The following predictors were found to be significant in the multivariate model: age of patient at visit, BMI z-score, age interaction with lung transplantation, insulin dependent diabetes, cirrhosis/portal hypertension, pancreatic insufficiency, Pseudomonas aeruginosa infection and baseline variability in FEV(1)pp. Those with P. aeruginosa infection had a lower mean difference in FEV(1)pp of 4.7 units, p < 0.001 compared to those who did not have the infection. Joint modelling with mortality outcome did not materially affect our findings. These models will prove useful for to study the impact of CFTR modulator therapies on rate of change of lung function among patients with CF. Nature Publishing Group UK 2020-10-15 /pmc/articles/PMC7567842/ /pubmed/33060788 http://dx.doi.org/10.1038/s41598-020-74502-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Earnest, Arul
Salimi, Farhad
Wainwright, Claire E.
Bell, Scott C.
Ruseckaite, Rasa
Ranger, Tom
Kotsimbos, Tom
Ahern, Susannah
Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry
title Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry
title_full Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry
title_fullStr Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry
title_full_unstemmed Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry
title_short Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry
title_sort lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567842/
https://www.ncbi.nlm.nih.gov/pubmed/33060788
http://dx.doi.org/10.1038/s41598-020-74502-1
work_keys_str_mv AT earnestarul lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry
AT salimifarhad lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry
AT wainwrightclairee lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry
AT bellscottc lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry
AT ruseckaiterasa lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry
AT rangertom lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry
AT kotsimbostom lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry
AT ahernsusannah lungfunctionoverthelifecourseofpaediatricandadultpatientswithcysticfibrosisfromalargemulticentreregistry